Wuppertal, Germany

Hans-Martin Siefert

This inventor holds 2 USPTO granted patents. Top assignees: Bayer Aktiengesellschaft, Bayeraktiengesellschaft. Active years: 2001-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans-Martin Siefert. Retrieved from https://idiyas.com/inventor/hans-martin-siefert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2001-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Hans-Martin Siefert

Introduction

Hans-Martin Siefert is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of pharmaceutical formulations, holding a total of 2 patents. His work focuses on innovative compositions and drug delivery systems that enhance therapeutic efficacy.

Latest Patents

Siefert's latest patents include "Imidazotriazinone-containing compositions for nasal administration." This invention relates to compositions that not only include a cGMP PDE inhibitor but also a small amount of a local anesthetic for improved nasal delivery. Another significant patent is for a "Medicament formulation with a controlled release of an active agent." This invention involves drug formulations that contain specific active compounds, designed to release their active ingredients at a defined rate, ensuring effective treatment.

Career Highlights

Throughout his career, Hans-Martin Siefert has worked with prominent companies such as Bayer Aktiengesellschaft. His experience in the pharmaceutical industry has allowed him to develop innovative solutions that address various medical needs.

Collaborations

Siefert has collaborated with notable colleagues, including Patrick Bosché and Heino Stass. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Hans-Martin Siefert's contributions to pharmaceutical innovations demonstrate his commitment to improving drug delivery systems. His patents reflect a deep understanding of the complexities involved in medication formulation and administration.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…